This HTML5 document contains 156 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n12http://dx.doi.org/10.1080/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37560954
rdf:type
wikibase:Item
schema:description
articolo scientifico videnskabelig artikel научни чланак scientific article published on 03 October 2016 bilimsel makale artículu científicu espublizáu en 2016 наукова стаття, опублікована в жовтні 2016 vědecký článek article científic article scientifique vetenskaplig artikel مقالة علمية نشرت في 03 أكتوبر 2016 artigo científico vedecký článok wetenschappelijk artikel wissenschaftlicher Artikel
p:P577
wds:Q37560954-533FB9C7-42D3-441C-BFBA-AA2023C3A171
wdt:P577
2016-10-03T00:00:00Z
p:P2860
wds:Q37560954-6E525332-97FF-4A16-B51C-85281B30DD2C wds:Q37560954-727320C8-C46E-48E5-81ED-2A89A85DAD9A wds:Q37560954-CE694226-7C2A-4516-B01E-47E17F65006B wds:Q37560954-CFCBBC04-4F64-4F3D-8652-8F28C9E3624E wds:Q37560954-C5BB2052-9A01-4609-B546-29137626028C wds:Q37560954-B5192F60-5303-4BF5-9BE2-F85B0A1BACB3 wds:Q37560954-987FF712-8A26-4BBF-9978-9CDAD236824F wds:Q37560954-A8287262-DA52-4E51-A987-A63A4D76F8D5 wds:Q37560954-DB2185C9-EAD8-4ECA-8E71-C444EB39F4BE wds:Q37560954-12D7E3A3-654F-4DA3-90B2-24337F70CBAB wds:Q37560954-17A2C217-0C11-4541-BC51-1D1E09E75ED7 wds:Q37560954-2443AED0-1AF0-44B9-9816-2A8E2DC011F3 wds:Q37560954-026145D7-BA42-4435-96F0-5D19E56AA06E wds:Q37560954-11285C0D-C7E1-4699-9413-CC1D53FCDE5D wds:Q37560954-59FB20B4-98B0-4A42-A147-26FE0810709F wds:Q37560954-5CD157A1-D061-4606-A43F-8F321ED882C8 wds:Q37560954-4D008AFB-8140-4F3F-B823-6F445C5BD8C7 wds:Q37560954-2544EFF5-F234-4CAA-B501-EA5D4ED706D5 wds:Q37560954-2C25160C-D827-4D8B-B198-AC54DAF46EFE wds:Q37560954-3098A0C2-2AE1-478B-A18E-1F39E135F855 wds:Q37560954-8F0581D5-0BAB-4007-B5A4-08FA64E25876 wds:Q37560954-8F59628D-6E73-4727-8094-BD3AEB06278C wds:Q37560954-95E1F6F4-1933-4077-90A6-57AE70F48C97 wds:Q37560954-87171D5C-9E34-4B99-8E18-0E7A44529A0E wds:Q37560954-8941B909-7860-480C-A351-3B2B825AE7E0 wds:Q37560954-8BCF2184-5A52-4CD3-B99D-E80CFCC56EC2 wds:Q37560954-84611077-15A2-4272-A7E1-4C51F7F1E6E7
wdt:P2860
wd:Q39447289 wd:Q30226730 wd:Q43963300 wd:Q45375388 wd:Q42790878 wd:Q30425045 wd:Q36956943 wd:Q57110756 wd:Q45734830 wd:Q29619463 wd:Q81694697 wd:Q34455910 wd:Q34170212 wd:Q47348983 wd:Q35715694 wd:Q33554684 wd:Q40929275 wd:Q33538308 wd:Q83276474 wd:Q34433416 wd:Q37643313 wd:Q47793480 wd:Q29615578 wd:Q30368814 wd:Q38443071 wd:Q39012223 wd:Q30400174
p:P2093
wds:Q37560954-C71639FD-CE69-4A27-9028-9E7947001414 wds:Q37560954-AFA99BCC-33B2-413F-9A0E-766A5FF4E9CC wds:Q37560954-8AADD86F-DB98-4978-B5E7-7C80E71D1A2A wds:Q37560954-7B553DBE-2CE9-454D-979A-4A32BBA226ED wds:Q37560954-D81067B6-5E53-46BA-AF71-6F036654BF2E wds:Q37560954-F7CDC778-56EA-419F-A2C6-B090C50E38CC
wdt:P2093
Walthère Dewé Anne Benoit Pierre Gervais Guillermo M Ruiz-Palacios Jiri Beran Xavier Duval
rdfs:label
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis
skos:prefLabel
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis
schema:name
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis
p:P50
wds:Q37560954-DD5A1028-3971-42CC-9E85-28F490DE5BF0 wds:Q37560954-FBBC7859-087B-4BD9-AC51-0FB6FDA8700D wds:Q37560954-29E3CED2-CD23-469B-A322-926BBD31B553 wds:Q37560954-3F9ABCC2-13C9-46D6-8CAA-35166FA2ACFC wds:Q37560954-45158CE4-4E85-4B47-8FD4-CE8FB321C04C wds:Q37560954-5B2A9502-DAEC-4BB6-A3A5-2D1DF277318B wds:Q37560954-5D12FFD0-1DAD-4E03-83F3-9AC85E7231D0 wds:Q37560954-06028E0B-A626-4C76-8853-CE25ACF0BB8B wds:Q37560954-14860635-DCE3-491A-A051-21B1C76382C3 wds:Q37560954-A4A931A9-1349-4D50-95CA-EA6410C5F481 wds:Q37560954-B42DD32B-49B5-4F29-92AC-94A886198CFE wds:Q37560954-C2D16839-C4BF-4707-9ABE-F716B3358EE7 wds:Q37560954-C5D4968F-E6E3-4C53-9D37-4168B1305AE3 wds:Q37560954-D6079325-E454-4F68-9F0E-8A84204076D8 wds:Q37560954-618DB592-F469-4BF1-B86D-9EDCE60BC9F5 wds:Q37560954-75608CB0-7459-4DD8-B35D-F8AA6BD4FEF4 wds:Q37560954-DCF5DCE5-3843-47BD-8951-CD91369FC0DD
wdt:P50
wd:Q45380570 wd:Q56433319 wd:Q114781838 wd:Q114781834 wd:Q114781837 wd:Q114402790 wd:Q112409277 wd:Q88952505 wd:Q89642185 wd:Q65089382 wd:Q92876176 wd:Q88812594 wd:Q91991389 wd:Q92484261 wd:Q57165117 wd:Q91075894 wd:Q91788032
p:P1476
wds:Q37560954-40849A37-2E56-4E0E-A0AA-4C6054AEBB8A
wdt:P1476
Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis
p:P304
wds:Q37560954-75582115-B6EB-4EDF-A4D7-02976EFAC7BF
wdt:P304
3043-3055
p:P31
wds:Q37560954-550E3358-4BF1-420B-8FE9-B791F331A19D
wdt:P31
wd:Q13442814
p:P921
wds:Q37560954-957AA5B9-76F2-4011-ABAE-91798E41A02A wds:Q37560954-F9F371C4-C233-48E4-A421-EC6C3D184157
wdt:P921
wd:Q42824827 wd:Q383260
p:P698
wds:Q37560954-C216395A-18AD-4264-B51D-E0FF54A737F9
wdtn:P698
n8:27690762
wdt:P698
27690762
p:P1433
wds:Q37560954-B5D90541-BD80-461D-A032-C713B0F12488
wdt:P1433
wd:Q21072749
p:P433
wds:Q37560954-6EAD44B6-10FF-41B0-829C-0950B30557AA
p:P478
wds:Q37560954-EA406FC3-7ACB-4291-B663-77BD049EDC37
wdt:P433
12
wdt:P478
12
p:P356
wds:Q37560954-4111E44F-FAF1-4979-B387-5C6E8701CA4E
wdtn:P356
n12:21645515.2016.1219809
wdt:P356
10.1080/21645515.2016.1219809
p:P275
wds:Q37560954-D803AC44-33CB-492E-B707-B516AF6BD35C
p:P6216
wds:Q37560954-57E3276A-B16B-4084-993D-126287F77A60
wdt:P275
wd:Q20007257
wdt:P6216
wd:Q50423863
p:P932
wds:Q37560954-DEE6A713-DD15-45A9-BA80-0239F63A07C2
wdt:P932
5215410